(Q44569647)

4 December 2017

0 references

Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites (English)

1 reference

4 December 2017

1 reference

Loi CM

1

1 reference

4 December 2017

Alvey CW

2

1 reference

4 December 2017

Randinitis EJ

3

1 reference

4 December 2017

Abel R

4

1 reference

4 December 2017

Young MA

5

1 reference

4 December 2017

Koup JR

6

1 reference

4 December 2017

publication date

1 November 1997

1 reference

The Journal of Clinical Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

37

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

1038-1047

1 reference

Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic Usefulness

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

In vitro studies on the action of CS-045, a new antidiabetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Hepatic drug metabolism and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Gender effects in pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Smoking and drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Sulfotransferase pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Influence of sex and oral contraceptive steroids on paracetamol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

Effect of diabetes mellitus on salivary paracetamol elimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04285.X

10.1002/J.1552-4604.1997.TB04285.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference